Pharma

Your Article Summary

See Latest Articles

Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Genzyme, 03/20/09

Genzyme Corporation announced that the European Medicines Agency's Committee for Human Medicinal Products has adopted a positive opinion for the marketing authorization of the new phosphate binder Renvela for use in patients with chronic kidney disease, including patients not on dialysis, with serum phosphorous levels >= 1.78 mmol/L.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

 See all of Drug/Product Approvals